Researchers have discovered that the expression of METTL3, a well-known RNA N6-methyladenosine catalytic core, is upregulated in most cancers, such as bladder cancer38, ovarian carcinoma39, breast cancer40, gastric cancer41, and NSCLC42. Here, METTL3 is linked to cancer.